DIVIS LABORATORIES
Back to Balance Sheet
|
DIVIS LABORATORIES Last 5 Year Capital Work in Progress History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Capital Work in Progress | ₹2,113 Cr | ₹1,022 Cr | ₹778 Cr | ₹212 Cr | ₹470 Cr |
What is the latest Capital Work in Progress ratio of DIVIS LABORATORIES ?
| Year | Capital Work in Progress |
|---|---|
| Mar2026 | ₹2,113 Cr |
| Mar2025 | ₹1,022 Cr |
| Mar2024 | ₹778 Cr |
| Mar2023 | ₹212 Cr |
| Mar2022 | ₹470 Cr |
How is Capital Work in Progress of DIVIS LABORATORIES Trending?
| Years | Capital Work in Progress | % Change | |
|---|---|---|---|
| Mar2026 | ₹2,113 Cr | 106.75 | |
| Mar2025 | ₹1,022 Cr | 31.36 | |
| Mar2024 | ₹778 Cr | 266.98 | |
| Mar2023 | ₹212 Cr | -54.89 | |
| Mar2022 | ₹470 Cr | - | |
Compare Capital Work in Progress of peers of DIVIS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DIVIS LABORATORIES | ₹220,140.7 Cr | 2.9% | 22.7% | 25.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹466,431.0 Cr | -2.3% | 3% | 12.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹188,853.0 Cr | -2.7% | 2% | 33.9% | Stock Analytics | |
| CIPLA | ₹119,158.0 Cr | 0.1% | 3% | -7% | Stock Analytics | |
| MANKIND PHARMA | ₹100,395.0 Cr | -1.6% | -2.3% | -4.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,074.4 Cr | 2.4% | -12.9% | -9.1% | Stock Analytics | |
DIVIS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DIVIS LABORATORIES | 2.9% |
22.7% |
25.5% |
| SENSEX | 1.3% |
1% |
-2.9% |
You may also like the below Video Courses